Article citationsMore>>
Lancet, J.E., et al. (2010) Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (KOS-1022, 17-DMAG) Administered Intravenously Twice Weekly to Patients with Acute Myeloid Leukemia. Leukemia, 24, 699-705.
https://doi.org/10.1038/leu.2009.292
has been cited by the following article:
Related Articles:
-
Tarek Elgohary, Fouad Abu-Taleb, Rania Ghonaim
-
Aditya Chakraborty, Chris P. Tsokos
-
Satoki Nakamura, Tomohiro Yagyu, Tomonari Takemura, Lin Tan, Yasuyuki Nagata, Daisuke Yokota, Isao Hirano, Kiyoshi Shibata, Michio Fujie, Shinya Fujisawa, Kazunori Ohnishi
-
Siyu Zhou, Yu Wu, Yili Cai, Zecheng Yu, Ruirui Li, Chunwei Yan, Fangwei Dai, Wei Han
-
Alioune Badara Diallo, Sokhna Aissatou Touré, Moussa Seck, Mouhamed Keita, Elimane Seydi Bousso, Blaise Felix Faye, Saliou Diop